OTHER GROUP COMPANIES
market

Kilitch Drugs starts production of Cephalosporin Injectables at Ethiopia Plant; Stock surges 5%

The Company had started its greenfield project in Ethiopia in 2018 to build a world-class Injectable plant.

July 26, 2021 2:35 IST | India Infoline News Service
Kilitch Drugs
Kilitch Drugs India Ltd, leading manufacturer of Injectables in India has announced that  it starts production of the Cephalosporin Injectables at Ethiopia manufacturing plant. The Company had started its greenfield project in Ethiopia in 2018 to build a world-class Injectable plant.

In early 2021 the company has started production of Antiseptic and Disinfectantproducts to help Ethiopia fight against the COVID-19 pandemic.

For Cephalosporin Injectables plant is having total capacity of 26.4 million vials yearly while Ethiopia is having a demand for 16 million Vials. Through this plant most of the capacity is going to be sold in Ethiopia through Government & other institutes.

Commenting on this Mr. Mukund Mehta, Chairman & Managing Director of Kilitch Drugs said “Africa always has been our focus market for our products.

We have started this manufacturing plant to cater to the African markets directly as there very few injectable manufacturing plants in whole continentand in turn help the people of Africa. Also, there is more demand than supply in the Ethiopia so we see that this has good business opportunity.”

At around 2:35 PM, Kilitch Drugs (India) was trading at Rs200.45 per piece up by Rs9.5 or 4.98% on Sensex.

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000

FEATURED ARTICLE

BLOGS

Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity